{"id":176238,"date":"2021-11-09T00:10:35","date_gmt":"2021-11-08T18:40:35","guid":{"rendered":"https:\/\/arunachaltimes.in\/?p=176238"},"modified":"2021-11-09T00:10:35","modified_gmt":"2021-11-08T18:40:35","slug":"pfizer-astrazeneca-covid-vaccines-generate-more-antibodies-than-natural-infection-study","status":"publish","type":"post","link":"https:\/\/arunachaltimes.in\/index.php\/2021\/11\/09\/pfizer-astrazeneca-covid-vaccines-generate-more-antibodies-than-natural-infection-study\/","title":{"rendered":"Pfizer, AstraZeneca Covid vaccines generate more antibodies than natural infection: Study"},"content":{"rendered":"<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">Toronto, Nov 8 (PTI) People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study published in Scientific Reports journal on Monday.<\/p>\n<p style=\"text-align: justify;\">A team led by researchers at the University of Montreal in Canada found that these antibodies were also effective against the Delta variant.<\/p>\n<p style=\"text-align: justify;\">In the study, 32 non-hospitalised COVID-19 positive Canadian adults were recruited 14 to 21 days after being diagnosed through PCR testing in 2020, before the Beta, Delta and Gamma variants emerged.<\/p>\n<p style=\"text-align: justify;\">&#8220;Everyone who had been infected produced antibodies, but older people produced more than adults under 50 years of age,&#8221; said Jean-Francois Masson, a professor at the University of Montreal.<\/p>\n<p style=\"text-align: justify;\">&#8220;In addition, antibodies were still present in their bloodstream 16 weeks after their diagnosis,&#8221; Masson said.<\/p>\n<p style=\"text-align: justify;\">Antibodies produced after an infection by the original viral strain also reacted to SARS-CoV-2 variants that emerged in subsequent waves, namely Beta, Delta and Gamma, with a reduction of 30 to 50 per cent in reactivity.<\/p>\n<p style=\"text-align: justify;\">&#8220;But the result that surprised us the most was that antibodies produced by naturally infected individuals 50 and older provided a greater degree of protection than adults below 50,&#8221; said Joelle Pelletier, a professor at the University of Montreal.<\/p>\n<p style=\"text-align: justify;\">&#8220;This was determined by measuring the antibodies&#8217; capacity to inhibit the interaction of the Delta variant&#8217;s spike protein with the ACE-2 receptor in human cells, which is how we become infected,&#8221; he added.<\/p>\n<p style=\"text-align: justify;\">The researchers, however, did not observe the same phenomenon with the other variants.<\/p>\n<p style=\"text-align: justify;\">They noted that when someone who has had a mild case of COVID is vaccinated, the antibody level in their blood doubles compared to an unvaccinated person who has been infected by the virus.<\/p>\n<p style=\"text-align: justify;\">Their antibodies are also better able to prevent spike-ACE-2 interaction, according to the researchers.<\/p>\n<p style=\"text-align: justify;\">&#8220;But what&#8217;s even more interesting is that we have samples from an individual younger than 49 whose infection didn&#8217;t produce antibodies inhibiting spike-ACE-2 interaction, unlike vaccination,&#8221; said Masson.<\/p>\n<p style=\"text-align: justify;\">&#8220;This suggests that vaccination increases protection against the Delta variant among people previously infected by the native strain,&#8221; Masson added.<\/p>\n<p style=\"text-align: justify;\">The researchers believe more research should be conducted to determine the best combination for maintaining the most effective level of antibodies reactive to all variants of the virus.<\/p>\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>Toronto, Nov 8 (PTI) People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study published in Scientific Reports journal on Monday. A team led by researchers at the University of Montreal in Canada found that these antibodies were also effective [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":{"0":"post-176238","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-world"},"_links":{"self":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts\/176238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/comments?post=176238"}],"version-history":[{"count":0,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/posts\/176238\/revisions"}],"wp:attachment":[{"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/media?parent=176238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/categories?post=176238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arunachaltimes.in\/index.php\/wp-json\/wp\/v2\/tags?post=176238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}